Publication | Closed Access
P3.02b-001 Phase 1 Dose Escalation of PF-06747775 (EGFR-T790M Inhibitor) in Patients with Advanced EGFRm (Del 19 or L858R+/-T790M) NSCLC
14
Citations
0
References
2017
Year
Advanced EgfrmDel 19Dose EscalationMedicinePharmacologyPharmacotherapyAnti-cancer AgentCancer TreatmentOncologyRadiation OncologyNovel TherapyMolecular Oncology
No additional data available for this publication yet. Check back later!